LRP5 rs886043590: Understanding This Rare Genetic Variant
The rs886043590 variant is a rare genetic change located within the LRP5 gene. It has been identified in clinical research in association with osteoporosis-pseudoglioma syndrome, a condition affecting bone density and vision.
What each genotype means
Associated with rare condition
This genotype involves an insertion of a T nucleotide in the LRP5 gene, which has been classified in clinical databases as pathogenic for Osteoporosis-pseudoglioma syndrome. This is a rare condition affecting bone density and vision, and individuals with this result should consult with a medical geneticist or healthcare provider for clinical context.
This genotype is extremely rare and is not typically found in the general population.
What is rs886043590?
The rs886043590 variant is a specific alteration in the human genome, cataloged in the dbSNP database. It is located on chromosome 11 at position 68,413,922. In genetic terms, this variant is often described as a duplication of a single nucleotide, specifically a thymine (T) insertion. Because it occurs within the LRP5 gene, it has the potential to alter the instructions the body uses to build specific proteins. Genetic variants like this are identified through advanced sequencing technologies that allow researchers to pinpoint exact locations on a chromosome where an individual's DNA sequence may differ from the standard reference genome.
The Role of the LRP5 Gene
The LRP5 gene provides instructions for making a protein called low-density lipoprotein receptor-related protein 5. This protein is a crucial component of the Wnt signaling pathway, which is essential for the development and maintenance of various tissues throughout the body. In particular, LRP5 plays a significant role in bone mass regulation and eye development. When the LRP5 gene functions correctly, it helps ensure that bone density is maintained and that the structures of the eye form properly. Mutations or variants in this gene can disrupt these signaling processes, which is why research into LRP5 is highly focused on understanding its impact on skeletal health and ocular development.
Clinical Associations and Evidence
Research has associated the rs886043590 variant with osteoporosis-pseudoglioma syndrome (OPPG). This is a rare, inherited disorder characterized by severe osteoporosis, which leads to fragile bones that break easily, and pseudoglioma, a condition that causes vision loss or impairment. The evidence for this association is derived from clinical genetic studies where this specific variant was identified in individuals presenting with these symptoms. It is important to note that while this variant is linked to a specific condition, the presence of a genetic variant does not always guarantee the development of a disease. Clinical interpretation of such variants is complex and requires professional medical evaluation to understand the full context of an individual's health.
Population Frequency
The rs886043590 variant is classified as rare in the general population. Because it is not a common polymorphism found in the majority of people, it is not typically included in standard ancestry-based genetic testing panels. Its rarity means that large-scale population studies have limited data on its distribution across different ethnic or geographic groups. When a variant is this rare, it is usually studied in the context of specific families or clinical cohorts where the condition it is associated with has been diagnosed. If you have received information about this variant from a clinical report, it is essential to discuss the findings with a genetic counselor or a medical specialist who can provide context based on your specific clinical history.
What You Can Do With This Information
Genetic information can be complex, and it is important to approach it with the guidance of a healthcare professional. If you have been informed that you carry the rs886043590 variant, you should not attempt to self-diagnose or make medical decisions based on this information alone. Instead, consult with a clinical geneticist or a physician who specializes in bone or eye health. They can help interpret what this means for your health, discuss potential screening or monitoring options, and provide support for your family members if necessary. Remember that genetic testing is a tool for information, and professional medical advice is the only way to translate that information into actionable health management.
How common is this variant?
The rs886043590 variant is considered rare in the general population, with limited data available regarding its frequency across diverse ancestral groups.
Frequently asked questions
What is osteoporosis-pseudoglioma syndrome?
Osteoporosis-pseudoglioma syndrome is a rare genetic disorder that causes very low bone density and vision problems. It is typically inherited in an autosomal recessive pattern.
Is rs886043590 the same as other LRP5 mutations?
No, rs886043590 is a specific variant. The LRP5 gene can have many different mutations, and each may have a different effect on the protein's function.
Should I be worried if I have this variant?
Genetic variants are only one part of your health picture. You should discuss any genetic findings with a doctor or genetic counselor to understand what they mean for you personally.
Where can I find more information on LRP5?
You can search resources like MedlinePlus Genetics or the National Institutes of Health (NIH) website for general information about the LRP5 gene and related conditions.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs886043590?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant in the IL2/IL21 locus shows genome-wide significant association with ulcerative colitis.
This variant acts as a hub gene marker associated with Th17 immune responses and hypo-inflammation in critically ill trauma patients.
An intronic regulatory variant in the LPP gene strongly associated with serum allergen-specific IgE levels and allergic rhinitis susceptibility.
A well-replicated intronic polymorphism in LPP associated with multi-allergen sensitization, including cat dander, dust mites, and grass pollen.
This intronic variant in the CASP8 gene is linked to prostate cancer risk assessment models.
This intronic variant is associated with improved risk stratification for clinically significant prostate cancer.